Result
€103,350 ▲ 270%
The result rose in 2025 from €27,936 to €103,350.
Epple
Overview
Lifetime
2 annual accounts with figures on one time axispeak €133,271 (2025)
€133,271▲ 274%
peak €103,350 (2025)
€103,350▲ 270%
peak €132,786 (2025)
€132,786▲ 351%
€13,991▲ 140%
Board2 names since 2024
2 directorsTIMMERMAN Stefan Benedikt Pieter Jan Maria and 1 other
Documentsfilings and deeds
16-07-202615 days before the deadline
2025micro format
Gross margin from €35,661 to €133,271Result from €27,936 to €103,350Equity from €29,436 to €132,786Debts from €5,838 to €13,991Cash from €28,879 to €138,618
Key points
from the 2025 annual accountsTurnover
≈ €250,000 estimated
The micro format states no turnover.
Investments
€3,500 60.8 × depreciation
Green is investment, beige is depreciation.
Liquidity
10.24 was 6.04 in 2024
Short-term debts rose from €5,838 to €13,991.
Starting capital
€1,500 100 shares
Position in the sector
90.5%
Higher solvency than 84% of companies in human health. Sector median 63.0% · 20,767 companies.
Checked score
99
Excellent
Financially stronger than 89% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
10-2025: < 0.1%
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: 0.1%▲ +0.1 percentage points vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026highest value
08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 10.24, cash €138,618
Equity €132,786 (90.5% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 97% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as Epple has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Epple itself is lower: < 0.1% within 12 months. It rests on far more data about Epple than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for Epple. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €13,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 10.24 (6.04 in 2024), above the usual 1.5. Short-term debt is 9.5% and cash 94.4% of total assets. 9.5% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
15 days early
2024
21 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 18 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- TIMMERMAN Stefan Benedikt Pieter Jan Maria founderdeed of 01-10-2024
- VANKEIRSBILCK Jasmine founderdeed of 01-10-2024
Recent changes
Registered office moved within Leuven
New registered office: Bottelarij 1/bus 0001, 3000 Leuven · Previous registered office: Schipvaartstraat 2/205, 3000 Leuven · Registered office clause: Schipvaartstraat 2/205, 3000 Leuven · Board meeting of 20-11-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1014248034
Incorporation
Founding capital of €1,500, 100 shares · Founders: TIMMERMAN Stefan Benedikt Pieter Jan Maria and VANKEIRSBILCK Jasmine · Appointments: TIMMERMAN Stefan Benedikt Pieter Jan Maria (director) and VANKEIRSBILCK Jasmine (director) · published on 01-10-2024 · Gazette deed
First establishment
Bottelarij 1, Leuven
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Epple Leuven | €146,777 | €133,271 | 90.5% | - |
| Medstrazdas Wemmel | €140,724 | €134,276 | 74.5% | - |
| AnesTHeezy Wezembeek-Oppem | €156,828 | €137,976 | 63.3% | - |
| DOKTER DIRK VAN GYSEL Roosdaal | €133,205 | €142,107 | 74.8% | - |
| Pura Vida Dermatologie Turnhout | €149,875 | €136,324 | 72.4% | - |
| ArthroS Oostkamp | €145,573 | €138,528 | 84.1% | - |
| Dr. Camille Le Moine, Reumatologie Lede | €140,080 | €128,964 | 81.0% | - |
These companies have the same main activity as Epple: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €133,000 and €157,000, founded in 2024.
Official details
Source: KBO- Status
- Active since 27-09-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220and 2 others
- Establishment unit
- 2.364.928.7893000 Leuven, since 27-09-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 28-10-2024
Annual accounts 2025
- €133,271▲ 274%
- €103,350▲ 270%
- €132,786▲ 351%
- €146,777▲ 316%
- Filing
- Filed on 16-07-2026, 15 days before the end of the filing period
Insights on Epple
Epple has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €132,786 and a net result of €103,350.
Its solvency ranks better than 84% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 16-07-2026, 15 days before the deadline€133,271
▲ 274%
€132,813
▲ 277%
€103,350
▲ 270%
€129,343
▲ 339%
90.5%
▲ 7.0 percentage points
10.24
▲ 4.20
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €250,000. Estimated: probably between €210,000 and €330,000.
Balance sheet
balance sheet total €146,777 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
90.5%
Higher than 84% of 20,767 companies in 2025.
10.24
Higher than 84% of 20,341 companies in 2025.
70.4%
Higher than 92% of 20,623 companies in 2025.
Epple
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
146,777 | 35,274 | |
21/28 |
3,442 | - | |
22/27 |
3,442 | - | |
23 |
3,442 | - | |
29/58 |
143,334 | 35,274 | |
40/41 |
4,208 | 6,004 | |
40 |
3,597 | 6,004 | |
41 |
611 | - | |
54/58 |
138,618 | 28,879 | |
490/1 |
508 | 392 | |
| Balance sheet: equity and liabilities | |||
10/49 |
146,777 | 35,274 | |
10/15 |
132,786 | 29,436 | |
10/11 |
1,500 | 1,500 | |
13 |
131,286 | 27,936 | |
133 |
131,286 | 27,936 | |
17/49 |
13,991 | 5,838 | |
42/48 |
13,991 | 5,838 | |
44 |
9,516 | 1,292 | |
440/4 |
9,516 | 1,292 | |
45 |
4,325 | 3,325 | |
450/3 |
3,325 | 3,325 | |
454/9 |
1,000 | - | |
47/48 |
150 | 1,221 | |
| Income statement | |||
9900 |
133,271 | 35,661 | |
630 |
58 | - | |
640/8 |
400 | 387 | |
9901 |
132,813 | 35,274 | |
65/66B |
75 | 13 | |
65 |
75 | 13 | |
9903 |
132,738 | 35,261 | |
67/77 |
29,389 | 7,325 | |
9904 |
103,350 | 27,936 | |
9905 |
103,350 | 27,936 | |
| Appropriation of the result | |||
9906 |
103,350 | 27,936 | |
691/2 |
103,350 | 27,936 | |
6921 |
103,350 | 27,936 | |
| Document | |||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 16-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 132,871 | - | ||
| 103,407 | - | ||
| 3,500 | - | ||
| 109,739 | - | ||
| 129,343 | 29,436 | ||
| 90.5% | 83.4% | ||
| 10.24 | 6.04 | ||
| 0.11 | 0.20 | ||
| 77.8% | 94.9% | ||
| 70.4% | 79.2% | ||
| over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | €3,500 | - |
| €58 | - |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on Epple
The operating result for 2025 is nearly 3.8 times that of 2024.
Debt's share of the balance-sheet total falls from 16.6% to 9.5%. Equity and debt are higher.
Board & ownership
Board
2 directors, since incorporationDirector (not named in the articles)
since 27-09-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 16-07-2026
Director (not named in the articles)
since 27-09-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 16-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 01-10-2024
Mandates through the years
2 names, the dashed line is todayTIMMERMAN Stefan Benedikt Pieter Jan Maria
Director (not named in the articles)
Director (not named in the articles)
VANKEIRSBILCK Jasmine
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- TIMMERMAN Stefan Benedikt Pieter Jan Maria
- Director (not named in the articles), from 26-09-2024 to date
- VANKEIRSBILCK Jasmine
- Director (not named in the articles), from 26-09-2024 to date
Control
This company
Epple
Equity €132,786
Profit €103,350 in 2025
Capital
- Contribution
- €1,500
- Shares
- 100
- Contribution per share
- €15
- Equity per share
- €1,328 in 2025
- Source
- deed of 01-10-2024
Articles of association
deed of 01-10-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“Tenminste helft leden aanwezig of vertegenwoordigd, verzaakt door alle bestuurders”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Friday of June at 20:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten artikel 2:87 Wetboek vennootschappen en verenigingen zonder bijzondere machtiging, algemene vergadering kan te allen tijde…”
Founders
At incorporation
deed of 01-10-2024 ↗
- TIMMERMAN Stefan Benedikt Pieter Jan Maria founder
- VANKEIRSBILCK Jasmine founder
Network & group
No group
Epple has no parent and no holdings in its annual accounts. Epple shares no director with another company.
Timeline
Timeline
7 events since 2024Filings
Financial
Establishments
Address
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 15 days before the deadline
Registered office moved within LeuvenNew registered office: Bottelarij 1/bus 0001, 3000 Leuven · Previous registered office: Schipvaartstraat 2/205, 3000 Leuven · Registered office clause: Schipvaartstraat 2/205, 3000 Leuven · Board meeting of 20-11-20253 points ▸
- Registered office clause, Schipvaartstraat 2/205, 3000 Leuven
- Board meeting, 20-11-2025
- Registered-office move, Bottelarij 1/bus 0001, 3000 Leuven
2025
Equity above €100,000 equity €132,786 ▲351% With a profit in every financial year since 2024, equity grows to €132,786.
Annual accounts 2024 filed NBBmicro format · 21 days before the deadline
2024
Registered in the Peppol Directory Reachable for e-invoices through 0208:1014248034
IncorporationFounding capital of €1,500, 100 shares · Founders: TIMMERMAN Stefan Benedikt Pieter Jan Maria and VANKEIRSBILCK Jasmine · Appointments: TIMMERMAN Stefan Benedikt Pieter Jan Maria (director) and VANKEIRSBILCK Jasmine (director) · published on 01-10-20245 points ▸
- Founder, TIMMERMAN Stefan Benedikt Pieter Jan Maria
- Founder, VANKEIRSBILCK Jasmine
- Founding capital, €1,500, 100 shares
- Director appointment, TIMMERMAN Stefan Benedikt Pieter Jan Maria (director (not named in the articles))
- Director appointment, VANKEIRSBILCK Jasmine (director (not named in the articles))
- The deed holds 3 more points.
First establishment Bottelarij 1, Leuven
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 1014.248.034
- VAT number
- BE 1014.248.034
- Peppol ID
- 0208:1014248034
- Other Peppol ID
- 9925:BE1014248034
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 27-09-2024
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Fourth Friday of June at 20:00deed of 01-10-2024 (in Dutch)
- Peppol
- Reachable since 28-10-2024Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- Epple in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 01-10-2024 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Schipvaartstraat 2/205, 3000 Leuven”deed of 01-10-2024 (in Dutch)
Activities
NACEBEL 202586220
Specialist medical practice main activity
86230
Dental practice
Codes under NACEBEL 2008
86220
Human health activities main activity
86230
Human health activities
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Preventieve en curatieve medische zorgverlening in de meest ruime zin van het woord; De uitoefening van de tandheelkunde in de meest…”deed of 01-10-2024 (in Dutch)
4 activities
- Preventieve en curatieve medische zorgverlening in de meest ruime zin van het woord;
- De uitoefening van de tandheelkunde in de meest uitgebreide zin door tandartsen onder hun persoonlijke en onbeperkte beroepsaansprakelijkheid.
- Het beheer over en de uitbating van één of meerdere tandartspraktijken evenals alle activiteiten met betrekking tot tandverzorging in het algemeen,waaronder het verwezenlijken,het leveren en de reparatie van tandprotheses,implantologie,orthodontie,paradontologie (of paradontie),de mond en tandchirurgie,occlusodontie,de prenvientieve tandgeneeskunde,de radiologie,et alle andere activiteiten met betrekking tot de tanden,in overeenstemming met de deontologie van het beroep.
- De honoraria voor de tandheelkundige verstrekkingen worden geïnd door en voor de vennootschap en de tandarts-aandeelhouders kunnen een vergoeding ontvangen van de vennootschap voor de door hun verrichte prestaties.
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Bottelarij 1 registered office 3000 Leuven | 27-09-2024 | 2.364.928.789 |
Buildings and parcels at the address
- Ground area
- 6,711 m²
- Buildings
- 71 m²
- Volume, LiDAR
- 941 m³
- Tallest building
- 13.7 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 24062A1134/00A000 | 6,711 m² | 1 · 71 m² | 13.7 m · 4 |